Rheumatology News

Lower levels of S100 proteins at baseline predict better treatment response with abatacept in patients with polyarticular-course juvenile idiopathic arthritis, according to data published in Arthritis Research & Therapy.

Patients treated with interleukin-23i or IL-12/23i for psoriasis exhibited similar rates of risk for developing psoriatic arthritis, according to a study.

In patients with rheumatoid arthritis who have an inadequate response to methotrexate, a treatment sequence beginning with a biosimilar appeared cost-effective compared with leflunomide, according to data published in JAMA Network Open.

Metformin may protect against the progression of adverse renal and cardiovascular outcomes in patients systemic lupus erythematosus, including lupus nephritis and infarction, according to data published in ACR Open Rheumatology.

On June 28, the U.S. Supreme Court ruled 6-3 in Loper Bright Enterprises v. Raimondo, Secretary of Commerce to overturn a decades-old decision known as the “Chevron deference.”

An eight-item questionnaire, called Central Aspects of Pain, reliably measures nociplastic pain across a variety of chronically painful musculoskeletal conditions, according to data published in Rheumatology.

Latin American patients with rheumatoid arthritis experience fewer serious adverse events, including major adverse cardiovascular events and malignancy, than patients who are not Latin American, according to a study.

The European Commission has granted marketing authorization for two devices that administer Bimzelx for the treatment of multiple inflammatory diseases, UCB announced in a press release.

A shared-care rheumatology clinic, where a rheumatologist saw patients virtually after another health care professional performed an initial assessment, was “successful by many metrics” and led to travel cost savings, according to a study.

It may be possible to forecast persistent disease activity in juvenile idiopathic arthritis using C-reactive protein-to-albumin ratio and neutrophil-to-lymphocyte ratio, according to data published in BMC Rheumatology.